Natrunix Versus Methotrexate in Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2023-02-15
Target enrollment:
Participant gender:
Summary
Phase II Double-Blinded, Placebo-Controlled Randomized Study Examining the Safety and
Efficacy of Natrunix versus MTX (+folate) for the Treatment of Rheumatoid Arthritis